ICYMI: New Investigational Treatment Could be a Step Forward Against Graft-versus-Host Disease
source: pixabay.com

ICYMI: New Investigational Treatment Could be a Step Forward Against Graft-versus-Host Disease

According to a story from Financial Buzz, the pharmaceutical company Elsayls Biotech is planning to submit a proposal to the European Medicines Agency (EMA) in order to conduct a clinical…

Continue Reading ICYMI: New Investigational Treatment Could be a Step Forward Against Graft-versus-Host Disease
Pfizer is Likely to Halt It’s Phase 3 Trial of a Treatment for Recurrent Kidney Cancer Following Disappointing Results
Source: Pixabay

Pfizer is Likely to Halt It’s Phase 3 Trial of a Treatment for Recurrent Kidney Cancer Following Disappointing Results

The phase 3 trial of the drug Inlyta for the treatment of patients with a high risk of recurrent renal cell carcinoma (kidney cancer) following nephrectomy (removal of a kidney)…

Continue Reading Pfizer is Likely to Halt It’s Phase 3 Trial of a Treatment for Recurrent Kidney Cancer Following Disappointing Results

CISCRP’s AWARE for All – D.C.

  • Post author:
  • Post category:

FREE educational program provided by CISCRP, The Center For Information & Study On Clinical Research Participation, created to educate the public about participating in clinical trial research.

Continue Reading CISCRP’s AWARE for All – D.C.
Delaying Epilepsy Onset in Young Children Could Improve Other Neurological Conditions
1041483 / Pixabay

Delaying Epilepsy Onset in Young Children Could Improve Other Neurological Conditions

Scientists are investigating whether delaying the onset of epilepsy in very young children could reduce or prevent other neurological conditions such as learning difficulties and autism, reports Medical Xpress. This…

Continue Reading Delaying Epilepsy Onset in Young Children Could Improve Other Neurological Conditions
Voice Technology and Cryptocurrency Changing Charcot-Marie-Tooth Disease Research
Source: Pixabay

Voice Technology and Cryptocurrency Changing Charcot-Marie-Tooth Disease Research

Collaboration often leads to greater success. Two advocacy groups, the Hereditary Neuropathy Foundation and True Reply have done just that to benefit patients with Charcot-Marie-Tooth disease. Their combined efforts focus…

Continue Reading Voice Technology and Cryptocurrency Changing Charcot-Marie-Tooth Disease Research
Update on Phase 2 Clinical Trial for a Drug to Treat CKD in Alport Syndrome Patients has Been Released
Source: Pixabay

Update on Phase 2 Clinical Trial for a Drug to Treat CKD in Alport Syndrome Patients has Been Released

A drug being developed to treat chronic kidney disease in Alport syndrome is showing promising results in patients in an on-going phase 2 clinical trial. Patients have shown an increase…

Continue Reading Update on Phase 2 Clinical Trial for a Drug to Treat CKD in Alport Syndrome Patients has Been Released
How are Zika and Hepatitis Related? A Repurposed Treatment for the Microcephaly-Causing Virus
Source: Pixabay.com

How are Zika and Hepatitis Related? A Repurposed Treatment for the Microcephaly-Causing Virus

A potential Zika treatment exists as a result of drug repurposing. The drug originally treated Hepatitis C. A new study highlights its potency against the microcephaly-causing Zika virus. Keep reading…

Continue Reading How are Zika and Hepatitis Related? A Repurposed Treatment for the Microcephaly-Causing Virus
Researchers Discover Causes of Graft-Verus-Host-Disease
Source: Pixabay

Researchers Discover Causes of Graft-Verus-Host-Disease

Research into graft-versus-host-disease (GVHD), a condition that can occur after bone marrow transplants, has yielded promising results. A study, reported by BrightSurf, found that a particular group of microRNA molecules involved…

Continue Reading Researchers Discover Causes of Graft-Verus-Host-Disease
Researchers Identify Predictive Factors for Pulmonary Hypertension in Scleroderma Patients
Source: Pixabay

Researchers Identify Predictive Factors for Pulmonary Hypertension in Scleroderma Patients

Patients with a form of scleroderma called systemic sclerosis are particularly susceptible to developing high blood pressure in their heart and lungs, also known as pulmonary hypertension. A new study…

Continue Reading Researchers Identify Predictive Factors for Pulmonary Hypertension in Scleroderma Patients